Fushun Kou
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Hudi enteric-coated capsule and its active constituent polydatin suppress Th1/Th17-mediated intestinal inflammation by modulating the KEAP1-NFE2L2 signaling pathway.
Journal: Precision clinical medicine
Published: March 31, 2026
Targeting the plasticity of intestinal neutrophils: bidirectional regulation strategies by natural products.
Journal: Frontiers in immunology
Published: November 25, 2025
YDJC restrains Th1 cell differentiation by blocking SREBP2-mediated cholesterol biosynthesis to alleviate mucosal inflammation in inflammatory bowel disease.
Journal: Cellular & molecular immunology
Published: October 31, 2024
Protective Effect of Qingchang Wenzhong Decoction on Colitis and Colitis-Related Carcinogenesis by Regulating Inflammation and Intestinal Fibrosis.
Journal: Journal of inflammation research
Published: December 22, 2022
Network Pharmacology Analysis of Hewei Jiangni Granule for Gastroesophageal Reflux Disease and Experimental Verification of Its Anti-Neurogenic Inflammation Mechanism.
Journal: Drug design, development and therapy
Published: November 25, 2021
Tongxie Anchang Decoction Relieves Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats by Regulating the NGF/TrkA Signaling Pathway.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: November 18, 2020
Systematic assessment of environmental factors for gastroesophageal reflux disease: An umbrella review of systematic reviews and meta-analyses.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: October 10, 2020
Network Pharmacology Identifies the Mechanisms of Action of Tongxie Anchang Decoction in the Treatment of Irritable Bowel Syndrome with Diarrhea Predominant.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: July 06, 2020
Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
Journal: Digestive diseases and sciences
Published: November 18, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026